Events

Pharmaceutical Life Cycle Management: Updates on Navigating the IP, FDA and Antitrust Terrain

Events / Wednesday, April 5, 2017

There’s been a sea change in the political climate. The regulatory forecast is still uncertain, and pharmaceutical evolution continues to develop.

Efforts to extend the life cycle of pharmaceutical products frequently involve innovations and improvements in product design, formulation, route of administration and treatment indications. In addition, negotiation of agreements with competitors, including generic and biosimilar manufacturers, is frequently employed as part of a life cycle management strategy. However, recent changes in patent, regulatory and antitrust laws have introduced considerable complexity and risk into these strategies.

Be prepared for what the next year may bring by attending this important webinar, which brings together our experienced professionals to talk about these issues and approaches for successful pharmaceutical life cycle management.

Presenters:
  • Carl W. Hittinger, Partner, Philadelphia
  • Lee H. Rosebush, Partner, Washington, D.C.
  • Lance L. Shea, Partner, Washington, D.C.
  • S. Maurice Valla, Partner, Philadelphia

Blog

In The Blogs

Previous Next
Health Law Update
Capitol Hill Healthcare Update
By Christian B. Jones
June 18, 2018
HOUSE OKs DOZENS OF OPIOID-RELATED BILLS; MORE VOTES SCHEDULED The House last week approved 38 bills that lawmakers hope will stem the opioid epidemic, and it scheduled votes this week on at least a dozen more. Most bills were...
Read More ->
IP Intelligence: Insight on Intellectual Property
USPTO Memo Addresses Eligibility of Method-of-Treatment Claims in View of Federal Circuit Decision
By David N. Farsiou
June 18, 2018
In a memorandum dated June 7, 2018 (Memo), the U.S. Patent and Trademark Office (USPTO) set out new guidance concerning method-of-treatment claims, which should be welcome news for patentees. The memo addressed the decision by the U.S...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
By Christian B. Jones
June 11, 2018
HOUSE TO VOTE ON DOZENS OF OPIOID BILLS WHILE SENATE READIES COMPREHENSIVE MEASURE The House this week will begin considering some of the 70 different opioid bills that have been approved by eight different committees, focusing on...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
By Christian B. Jones
May 21, 2018
RYAN SAYS POTENTIAL COMPROMISE COMING ON RISK EVALUATION AND MITIGATION STRATEGY DRUGS House Speaker Paul Ryan, R-Wis., last week said congressional leaders are trying to hammer out compromise legislation that would make it easier for...
Read More ->
Antitrust Advocate
Class Actions Now Flowing From FTC and DOJ's No-Poach Enforcement
By Tyson Y. Herrold, Carl W. Hittinger
May 15, 2018
Partner Carl Hittinger and Associate Tyson Herrold authored an article published by The Legal Intelligencer on May 5, 2018. The article, “Class Actions Now Flowing from FTC and DOJ’s No-Poach Enforcement,” discusses the increase of class...
Read More ->